Cargando…
Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model
In addition to its role in the treatment of pancreatitis, the serine protease inhibitor nafamostat exhibits a retinal protective effect. However, the exact mechanisms underlying this effect are unknown. In this study, the neuroprotective effects of nafamostat and its orally active derivative sepimos...
Autores principales: | Fuwa, Masahiro, Kageyama, Masaaki, Ohashi, Koji, Sasaoka, Masaaki, Sato, Ryuichi, Tanaka, Masami, Tashiro, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938488/ https://www.ncbi.nlm.nih.gov/pubmed/31892740 http://dx.doi.org/10.1038/s41598-019-56905-x |
Ejemplares similares
-
Mechanisms of NMDA Receptor Inhibition by Sepimostat—Comparison with Nafamostat and Diarylamidine Compounds
por: Zhigulin, Arseniy S., et al.
Publicado: (2023) -
Novel use of a chemically modified siRNA for robust and sustainable in vivo gene silencing in the retina
por: Taniguchi, Takazumi, et al.
Publicado: (2020) -
Rotenone-induced inner retinal degeneration via presynaptic activation of voltage-dependent sodium and L-type calcium channels in rats
por: Sasaoka, Masaaki, et al.
Publicado: (2020) -
Novel common variants and susceptible haplotype for exfoliation glaucoma specific to Asian population
por: Nakano, Masakazu, et al.
Publicado: (2014) -
Neuroprotection by MKK7 inhibition in excitotoxicity
por: Vercelli, Alessandro, et al.
Publicado: (2015)